KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLoans - NetLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesReal Estate - NetReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthpeak Properties (DOC) Other Non-Current Assets (2016 - 2025)

Healthpeak Properties (DOC) has disclosed Other Non-Current Assets for 16 consecutive years, with $70.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 8.93% to $70.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $70.2 million, a 8.93% increase, with the full-year FY2025 number at $70.2 million, up 8.93% from a year prior.
  • Other Non-Current Assets was $70.2 million for Q4 2025 at Healthpeak Properties, down from $945.5 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $945.5 million in Q3 2025 to a low of $50.4 million in Q3 2023.
  • A 5-year average of $189.5 million and a median of $57.4 million in 2023 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: crashed 74.98% in 2021, then surged 1597.47% in 2025.
  • Healthpeak Properties' Other Non-Current Assets stood at $53.5 million in 2021, then increased by 2.52% to $54.8 million in 2022, then fell by 6.23% to $51.4 million in 2023, then rose by 25.49% to $64.5 million in 2024, then increased by 8.93% to $70.2 million in 2025.
  • Per Business Quant, the three most recent readings for DOC's Other Non-Current Assets are $70.2 million (Q4 2025), $945.5 million (Q3 2025), and $940.3 million (Q1 2025).